A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules

Sponsor
Vanderbilt-Ingram Cancer Center
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT06074133
This is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.
Intervention
Blood collection, Chest Computed Tomography
Condition
Pulmonary Nodule
Investigators
Eric Grogan, MD, Vanderbilt-Ingram Service Services for Timely Access, Melissa New, MD, Anna 'Baron, PhD, Vanderbilt-Ingram Services for Timely Access

See list of participating sites